浙江東方(600120.SH):子公司擬出資2億元投資浦東引領區科創一號基金
格隆匯6月20日丨浙江東方(600120.SH)公佈,公司全資子公司東方產融擬認繳出資2億元人民幣,作為有限合夥人投資浦東引領區科創一號基金。浦東引領區科創一號基金認繳出資規模不低於40億元人民幣(目前意向認繳規模41億元),存續期為8年,其中投資期4年,退出期4年,由執行事務合夥人提出議案,經合夥人會議決定可一次或多次延長。
浦東引領區科創一號基金將重點投資於包括但不限於以下產業:新興科技、醫療健康、綠色發展等產業。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.